Home / Drug shortages / Methotrexate Sodium Injection

Methotrexate Sodium Injection — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Methotrexate Sodium Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 03/13/2023.

Shortage Details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0703-3678-01
Dosage Form
Injection
Presentation
Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)
Initial Posting
03/13/2023
Revised Date

FDA data resources